A Multi-Center, Ascending Dose Trial to Assess the Safety, Pharmacokinetics and Pharmacodynamics of CD-NP Infusions in Patients With Congestive Heart Failure.
Latest Information Update: 30 May 2009
Price :
$35 *
At a glance
- Drugs Cenderitide (Primary)
- Indications Heart failure
- Focus Adverse reactions
- 27 May 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 27 May 2009 Actual end date (Dec 2008) added as reported by ClinicalTrials.gov.
- 19 Oct 2008 Planned end date changed from May 2008 to Nov 2008, as reported by ClinicalTrials.gov.